Essay About The Supreme Court Clean Energy Essay Full Sentences Using Acronyms In An Essay College Level Essay Rubric Read Essay On Wife Of Bath Canterbury Tales Character Analysis June 2004 Global Regents Dbq Essay

Moderna, BioNTech, Pfizer Fall on Merck Covid-19 Pill News

This post was originally published on this site

Investing.com — Shares in the makers of Covid-19 vaccines all fell sharply in premarket trading on Friday on expectations that Merck’s experimental pill for treating the disease could radically undercut future demand for their drugs. 

By (8:45 AM ET 1345 GMT), Moderna (NASDAQ:MRNA) stock was down 4.9%, while BioNTech stock was down 5.3% and Pfizer (NYSE:PFE) stock was down 1.9%.  Pfizer has traditionally been the least price-sensitive to vaccine news because it has many other revenue sources, whereas the other two are, for the present at least, pure plays on Covid-19 treatments. 

Merck (NYSE:MRK) had said earlier that an early-stage trial of its experimental pill had led to clear reductions in hospitalizations among the sample group, all of whom had taken it after developing moderate symptoms of Covid-19. 

The study was stopped early, as is often the case when an experimental drug shows signs of efficacy.

Scientists have searched feverishly for a Covid-19 remedy that can be manufactured, distributed and administered at massive scale without arousing the suspicions and mistrust that often accompany new vaccines. Such a pill could transform the vaccination status of many poorer countries, where Covid-19 is still spreading more or less unimpeded due to the lack of vaccines in the developing world. 

Add Comment